Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations

作者: Murray Joseph Casey , Carrie Synder , Chhanda Bewtra , Steven A. Narod , Patrice Watson

DOI: 10.1016/J.YGYNO.2005.01.039

关键词:

摘要: Abstract Objective Prophylactic surgical removal of the ovaries has been offered for many years as a potential preventative ovarian cancer in women deemed to be at increased hereditary risk this disease. Now, it is possible test specific mutations BRCA1 and BRCA2 genes that render members breast (HBOC) syndrome families susceptible cancer. Widespread intra-abdominal carcinomatosis, which mimics metastatic serous carcinoma, reported following oophorectomy individuals risk. This study was undertaken examine report particularly occurrence well other cancers, prophylactic patients who carry susceptibility assess cumulative risks disease order assist developing appropriate interventions, based on currently available information, counsel choose surgery, concerning prognosis, thereafter. Methods The Creighton University Hereditary Cancer Institute registry searched HBOC had undergone oophorectomy. histories results DNA testing carried their were recorded, tabulated examined, aggregate data are along with pertinent details those developed neoplastic diseases after All histologic cytologic materials diagnosed carcinomatosis reviewed, life-table calculations performed Results From 72 either or cancer-associated mutations, 238 recorded our between January 1985 December 2002. During mean follow-up 9.3 years, cancers 27 subjects, including 16 five carcinomatosis. Breast stage I 10 12 proven carriers mutations. cases carcinomas, all occurred mutation carriers. Histologic review prophylactically removed found borderline lesions two cases, one early stromal invasion. Two among 78 series treated before A 3.5% 3.9% calculated through 20 Conclusions Intra-abdominal only families, specifically deleterious below estimated published literature similar patients. tended small localized, most common malignancy

参考文章(91)
Jurgen M. J. Piek, Bas Torrenga, Brenda Hermsen, René H. M. Verheijen, Ronald P. Zweemer, Johan J. P. Gille, Peter Kenemans, Paul J. van Diest, Fred H. Menko, Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study. Familial Cancer. ,vol. 2, pp. 73- 78 ,(2003) , 10.1023/A:1025700807451
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
Tucker Ma, Struewing Jp, Ponder Ba, Watson P, Lynch Ht, Easton Df, Prophylactic oophorectomy in inherited breast/ovarian cancer families. Journal of The National Cancer Institute Monographs. pp. 33- 35 ,(1995)
S Narod, D Goldgar, J Eyfjord, D Easton, G Lenoir, O Serova, P Devilee, D Ford, R B Barkardottir, Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 57, pp. 957- 958 ,(1995)
Elizabeth L. Schubert, Jamie L. Dann, Jan E. Morrow, Mary Claire King, Ming K. Lee, Judy Hull, Rhodora H. Argonza, Heather C. Mefford, BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2 American Journal of Human Genetics. ,vol. 60, pp. 1031- 1040 ,(1997)
Steven A. Narod, Gilbert M. Lenoir, Jean Feunteun, Patricia Tonin, Bakary Sylla, Henry T. Lynch, Delphine Torchard, Marco Montagna, Olga Serova, A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. American Journal of Human Genetics. ,vol. 58, pp. 42- 51 ,(1996)
Rena Vassilopoulou-Sellin, Deborah S. Cohen, Gabriel N. Hortobagyi, Mary Jean Klein, Marsha McNeese, S. Eva Singletary, Terry L. Smith, Richard L. Theriault, Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study. Cancer. ,vol. 95, pp. 1817- 1826 ,(2002) , 10.1002/CNCR.10913
S.A. Narod, J.E. Garber, S.A. Smith, P. Devilee, H.T. Lynch, B.A.J. Ponder, B.L. Weber, J.M. Birch, R.B. Barkardottir, D. Ford, An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 254- 264 ,(1995)
J A Roy, C A Sawka, K I Pritchard, Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits Journal of Clinical Oncology. ,vol. 14, pp. 997- 1006 ,(1996) , 10.1200/JCO.1996.14.3.997
Karen H. Lu, Judy E. Garber, Daniel W. Cramer, William R. Welch, Jonathan Niloff, Deborah Schrag, Ross S. Berkowitz, Michael G. Muto, Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. Journal of Clinical Oncology. ,vol. 18, pp. 2728- 2732 ,(2000) , 10.1200/JCO.2000.18.14.2728